This is stems from the Hygea deal being a dud. This much vaunted announcement of up to $US 22 million was just pure deception on value, length and the commitment to the contract. The American medical market has looked it over and stayed away in droves. Can the reputational damage in the USA be repaired?
The happy clappers?
- Forums
- ASX - By Stock
- GMV
- News: GMV G Medical Innovations Holdings Ltd Files To Withdraw U.S. IPO Plans
News: GMV G Medical Innovations Holdings Ltd Files To Withdraw U.S. IPO Plans, page-18
-
- There are more pages in this discussion • 45 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add GMV (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online